Audrey Kunin, Chief Product Officer at NovaBay Pharmaceuticals, Inc. (NBY), bought 30,000 shares at $0.46 ($14K) on 2021-11-30, disclosed to the SEC on 2021-12-02.
Open-market purchase of $14k NBY by Chief Product Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| NBY | SELL | 2022-09-16 | $47K | — | Filing → |
| NBY | BUY | 2021-12-07 | $47K | — | Filing → |
| NBY | BUY | 2021-12-06 | $252K | — | Filing → |